Abstract
In the context of the metabolic reprogramming of tumor cells (Warburg effect), a variety of proteins show enhanced expression, including monocarboxylate transporters (MCTs). Recently, MCT1 was identified as a major determinant of the sensitivity to 3- bromopyruvate (3-BP), one of the most promising inhibitors of glycolytic metabolism. Melanoma is the most aggressive form of skin cancer an…